Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 11:34 am Purchase | 2020-12-31 | 13G | Giga-tronics Incorporated GIGA | Lytton, Laurence W. | 247,700 9.400% | 1,900 (+0.77%) | Filing History |
| 2021-02-16 11:32 am Sale | 2020-12-31 | 13G | EMCORE Corporation EMKR | Lytton, Laurence W. | 171,830 5.800% | -104,058 (-37.72%) | Filing History |
| 2021-02-16 11:30 am Sale | 2020-12-31 | 13G | Duos Technologies Group, Inc. DUOT | Lytton, Laurence W. | 215,700 6.100% | -67,300 (-23.78%) | Filing History |
| 2021-02-16 11:26 am Purchase | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Lytton, Laurence W. | 15,813 9.990% | 7,805 (+97.45%) | Filing History |
| 2021-02-16 11:22 am Sale | 2020-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Lytton, Laurence W. | 2,648,150 9.990% | -17,782 (-0.67%) | Filing History |
| 2021-01-04 12:35 pm Purchase | 2020-12-22 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | Lytton, Laurence W. | 1,598,519 8.800% | 1,598,519 (New Position) | Filing History |